P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000891000.99990.30 |
_version_ | 1797287782816677888 |
---|---|
author | Eleonora Calabretta Martina Di Trani Martina Sollini Francesca Ricci Francesco Corrado Vanessa Cristaldi Stefanos Bonovas Fabrizio Marino Rita Mazza Lodovico Terzi Di Bergamo Alessio Bruscaggin Maria Cristina Pirosa Stefania Bramanti Arturo Chiti Armando Santoro Davide Rossi Carmelo Carlo-Stella |
author_facet | Eleonora Calabretta Martina Di Trani Martina Sollini Francesca Ricci Francesco Corrado Vanessa Cristaldi Stefanos Bonovas Fabrizio Marino Rita Mazza Lodovico Terzi Di Bergamo Alessio Bruscaggin Maria Cristina Pirosa Stefania Bramanti Arturo Chiti Armando Santoro Davide Rossi Carmelo Carlo-Stella |
author_sort | Eleonora Calabretta |
collection | DOAJ |
first_indexed | 2024-03-07T18:39:53Z |
format | Article |
id | doaj.art-f2e5e94b80cb4f989e13cc4427596614 |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T18:39:53Z |
publishDate | 2022-10-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-f2e5e94b80cb4f989e13cc44275966142024-03-02T04:19:17ZengWileyHemaSphere2572-92412022-10-016505110.1097/01.HS9.0000891000.99990.30202210005-00108P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphomaEleonora Calabretta0Martina Di Trani1Martina Sollini2Francesca Ricci3Francesco Corrado4Vanessa Cristaldi5Stefanos Bonovas6Fabrizio Marino7Rita Mazza8Lodovico Terzi Di Bergamo9Alessio Bruscaggin10Maria Cristina Pirosa11Stefania Bramanti12Arturo Chiti13Armando Santoro14Davide Rossi15Carmelo Carlo-Stella161 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy2 Department of Oncology and Hematology, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy2 Department of Oncology and Hematology, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy4 Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland4 Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland5 Oncology Institute of Southern Switzerland, Bellinzona, Switzerland2 Department of Oncology and Hematology, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy4 Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italyhttp://journals.lww.com/10.1097/01.HS9.0000891000.99990.30 |
spellingShingle | Eleonora Calabretta Martina Di Trani Martina Sollini Francesca Ricci Francesco Corrado Vanessa Cristaldi Stefanos Bonovas Fabrizio Marino Rita Mazza Lodovico Terzi Di Bergamo Alessio Bruscaggin Maria Cristina Pirosa Stefania Bramanti Arturo Chiti Armando Santoro Davide Rossi Carmelo Carlo-Stella P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma HemaSphere |
title | P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma |
title_full | P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma |
title_fullStr | P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma |
title_full_unstemmed | P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma |
title_short | P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma |
title_sort | p108 integrating baseline circulating tumor dna with interim pet improves outcome prediction in relapsed refractory classical hodgkin lymphoma |
url | http://journals.lww.com/10.1097/01.HS9.0000891000.99990.30 |
work_keys_str_mv | AT eleonoracalabretta p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT martinaditrani p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT martinasollini p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT francescaricci p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT francescocorrado p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT vanessacristaldi p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT stefanosbonovas p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT fabriziomarino p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT ritamazza p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT lodovicoterzidibergamo p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT alessiobruscaggin p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT mariacristinapirosa p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT stefaniabramanti p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT arturochiti p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT armandosantoro p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT daviderossi p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma AT carmelocarlostella p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma |